In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
Abbott and the United States Department of Defense today announced a collaboration with the intent to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain injuries (TBIs). As part of a multi–phased approach, the tests would be developed for Abbott’s i–STAT® System, a handheld, diagnostic analyzer that is currently used for other point-of-care testing, including among military service members. Concussions are a significant health concern for military service members.1 With the development of new tests, physicians could use the information to positively impact the care of people with a suspected concussion.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7293951-abbott-u-s-department-of-defense-develop-portable-blood-tests-concussions/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
New science in molecular and genetic testing for breast, colon, and prostate cancer, as well as leukemia, will be among the special features at the College of American Pathologists’ annual scientific and education meeting, CAP’14—THE Pathologists’ Meeting, Sept. 7-10 at the Hyatt Regency in Chicago.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7270051-college-of-american-pathologists-cap-14-what-s-next-in-cancer-testing/
The full set of data from EUCLID, the largest ever prevalence study of Clostridium difficile infection (CDI) across Europe, were presented today at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Data from 482 European hospitals reveal that in a single day, an average of 109 cases of CDI are missed due to a lack of clinical suspicion or inadequate laboratory testing, potentially leading to more than 39,000 missed cases in Europe each year.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400524-EUCLID-clostridium-difficile-infection
Rachael Ray and Guy Fieri return to mentor and coach eight new multi-talented celebrities in the third season of Rachael vs. Guy: Celebrity Cook-Off, premiering Monday, January 6th at 9pm ET/PT on Food Network. The eight celebrities are divided into Team Rachael and Team Guy as they compete over six episodes in a variety of culinary challenges, testing their cooking, marketing and performing skills along the way. New to this season, each episode features a special Food Network guest judge who will determine which celebrity is sent home. The last one left standing wins bragging rights as they join past season winners Lou Diamond Phillips and Dean McDermott, and $50,000 to the charity of their choice.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/63840-food-network-rachael-vs-guy-celebrity-cook-off
HemoCue America, a global leader in advanced point-of-care testing (POCT) systems, announced on October 9, 2013 that the American Red Cross, the world’s largest blood bank organization, has signed a five-year agreement on instruments and consumables for hemoglobin testing of blood donors.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63473-hemocue-red-cross-supply-agreement
What\'s the wisdom of Allah in these testing times??
A session by Daee Ahmed Moait covering topics:
- The Ummah in tribulations ..
- The Mercy taught to us by our teacher, Muhammad SAW
- Sanctity of a soul ...
- are the animals and beasts laughing at us??
- Verses from Qur\'an about the hypocrites and the people who are veiled
- trials to some, Mercy to some...
What's the wisdom of Allah in these testing times??
A session by Daee Ahmed Moait covering topics:
- The Ummah in tribulations ..
- The Mercy taught to us by our teacher, Muhammad SAW
- Sanctity of a soul ...
- are the animals and beasts laughing at us??
- Verses from Qur'an about the hypocrites and the people who are veiled
- trials to some, Mercy to some...
What's the wisdom of Allah in these testing times??
A session by Daee Ahmed Moait covering topics:
- The Ummah in tribulations ..
- The Mercy taught to us by our teacher, Muhammad SAW
- Sanctity of a soul ...
- are the animals and beasts laughing at us??
- Verses from Qur'an about the hypocrites and the people who are veiled
- trials to some, Mercy to some...
What's the wisdom of Allah in these testing times??
A session by Daee Ahmed Moait covering topics:
- The Ummah in tribulations ..
- The Mercy taught to us by our teacher, Muhammad SAW
- Sanctity of a soul ...
- are the animals and beasts laughing at us??
- Verses from Qur'an about the hypocrites and the people who are veiled
- trials to some, Mercy to some...
What's the wisdom of Allah in these testing times??
A session by Daee Ahmed Moait covering topics:
- The Ummah in tribulations ..
- The Mercy taught to us by our teacher, Muhammad SAW
- Sanctity of a soul ...
- are the animals and beasts laughing at us??
- Verses from Qur'an about the hypocrites and the people who are veiled
- trials to some, Mercy to some...
